Literature DB >> 28494157

Side Fenestrations Provide an "Anchor" for a Stable Binding of A1899 to the Pore of TASK-1 Potassium Channels.

David Ramírez1,2, Bárbara Arévalo1, Gonzalo Martínez1, Susanne Rinné3, Francisco V Sepúlveda4, Niels Decher3, Wendy González1.   

Abstract

A1899 is a potent and selective inhibitor of the two-pore domain potassium (K2P) channel TASK-1. It was previously reported that A1899 acts as an open-channel blocker and binds to residues of the P1 and P2 regions, the M2 and M4 segments, and the halothane response element. The recently described crystal structures of K2P channels together with the newly identified side fenestrations indicate that residues relevant for TASK-1 inhibition are not purely facing the central cavity as initially proposed. Accordingly, the TASK-1 binding site and the mechanism of inhibition might need a re-evaluation. We have used TASK-1 homology models based on recently crystallized K2P channels and molecular dynamics simulation to demonstrate that the highly potent TASK-1 blocker A1899 requires binding to residues located in the side fenestrations. Unexpectedly, most of the previously described residues that interfere with TASK-1 blockade by A1899 project their side chains toward the fenestration lumina, underlining the relevance of these structures for drug binding in K2P channels. Despite its hydrophobicity, A1899 does not seem to use the fenestrations to gain access to the central cavity from the lipid bilayer. In contrast, binding of A1899 to residues of the side fenestrations might provide a physical "anchor", reflecting an energetically favorable binding mode that after pore occlusion stabilizes the closed state of the channels.

Entities:  

Keywords:  A1899; TASK-1; drug−protein interaction; ion channels; molecular docking; molecular dynamics

Mesh:

Substances:

Year:  2017        PMID: 28494157     DOI: 10.1021/acs.molpharmaceut.7b00005

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  10 in total

1.  Screening for Interacting Proteins with Peptide Biomarker of Blood-Brain Barrier Alteration under Inflammatory Conditions.

Authors:  Karina Vargas-Sanchez; Monica Losada-Barragán; Maria Mogilevskaya; Susana Novoa-Herrán; Yehidi Medina; Cristian Buendía-Atencio; Vaneza Lorett-Velásquez; Jessica Martínez-Bernal; Rodrigo E Gonzalez-Reyes; David Ramírez; Klaus G Petry
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

2.  Energetic differences between non-domain-swapped and domain-swapped chain connectivities in the K2P potassium channel TRAAK.

Authors:  Carlos Navarro-Retamal; Julio Caballero
Journal:  RSC Adv       Date:  2018-07-25       Impact factor: 3.361

3.  The molecular basis for an allosteric inhibition of K+-flux gating in K2P channels.

Authors:  Susanne Rinné; Aytug K Kiper; Kirsty S Vowinkel; David Ramírez; Marcus Schewe; Mauricio Bedoya; Diana Aser; Isabella Gensler; Michael F Netter; Phillip J Stansfeld; Thomas Baukrowitz; Wendy Gonzalez; Niels Decher
Journal:  Elife       Date:  2019-02-26       Impact factor: 8.140

Review 4.  HCN Channels: New Therapeutic Targets for Pain Treatment.

Authors:  David Ramírez; Rafael Zúñiga; Guierdy Concha; Leandro Zúñiga
Journal:  Molecules       Date:  2018-08-21       Impact factor: 4.411

5.  Structure/Activity Analysis of TASK-3 Channel Antagonists Based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine.

Authors:  David Ramírez; Mauricio Bedoya; Aytug K Kiper; Susanne Rinné; Samuel Morales-Navarro; Erix W Hernández-Rodríguez; Francisco V Sepúlveda; Niels Decher; Wendy González
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

6.  Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening.

Authors:  David Ramírez; Guierdy Concha; Bárbara Arévalo; Luis Prent-Peñaloza; Leandro Zúñiga; Aytug K Kiper; Susanne Rinné; Miguel Reyes-Parada; Niels Decher; Wendy González; Julio Caballero
Journal:  Int J Mol Sci       Date:  2019-08-17       Impact factor: 5.923

7.  Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels.

Authors:  Antonius Ratte; Felix Wiedmann; Manuel Kraft; Hugo A Katus; Constanze Schmidt
Journal:  Front Pharmacol       Date:  2019-11-26       Impact factor: 5.810

8.  Structural Insights into the Substrate Transport Mechanisms in GTR Transporters through Ensemble Docking.

Authors:  Carlos Peña-Varas; Christa Kanstrup; Ariela Vergara-Jaque; Mariela González-Avendaño; Christoph Crocoll; Osman Mirza; Ingo Dreyer; Hussam Nour-Eldin; David Ramírez
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

9.  5-(Indol-2-yl)pyrazolo[3,4-b]pyridines as a New Family of TASK-3 Channel Blockers: A Pharmacophore-Based Regioselective Synthesis.

Authors:  David Ramírez; Melissa Mejia-Gutierrez; Braulio Insuasty; Susanne Rinné; Aytug K Kiper; Magdalena Platzk; Thomas Müller; Niels Decher; Jairo Quiroga; Pedro De-la-Torre; Wendy González
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

10.  Elucidating the Structural Basis of the Intracellular pH Sensing Mechanism of TASK-2 K2P Channels.

Authors:  Daniel Bustos; Mauricio Bedoya; David Ramírez; Guierdy Concha; Leandro Zúñiga; Niels Decher; Erix W Hernández-Rodríguez; Francisco V Sepúlveda; Leandro Martínez; Wendy González
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.